About Strella Biotech
Strella Biotech is a company based in Philadelphia (United States) founded in 2018. Strella Biotech has raised $11.32 million across 4 funding rounds from investors including Union Labs, Catapult Ventures and Yamaha Motor Ventures. The company has 12 employees as of December 31, 2021. Strella Biotech offers products and services including Store, Ripen, Sequence, and Monitor. Strella Biotech operates in a competitive market with competitors including Allergy Amulet, ClariFruit, SensoGenic, Crystal Diagnostics and Dots, among others.
- Headquarter Philadelphia, United States
- Employees 12 as on 31 Dec, 2021
-
Sectors
TechnologyAgriculture
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Strella Biotechnology, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$11.32 M (USD)
in 4 rounds
-
Latest Funding Round
$5.6 M (USD), Debt – Conventional
Feb 21, 2024
-
Investors
Union Labs
& 11 more
-
Employee Count
12
as on Dec 31, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Strella Biotech
Strella Biotech offers a comprehensive portfolio of products and services, including Store, Ripen, Sequence, and Monitor.
Predicts produce maturity to reduce waste in storage
Automates processes for fruit and vegetable ripening
Optimizes produce shipout to minimize shrink
Provides real-time monitoring of produce supply chain conditions
People of Strella Biotech
Unlock access to complete
Funding Insights of Strella Biotech
Strella Biotech has successfully raised a total of $11.32M across 4 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $5.6 million completed in February 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Strella Biotech
Strella Biotech has secured backing from 12 investors, including venture fund, angel, and institutional investors. Prominent investors backing the company include Union Labs, Catapult Ventures and Yamaha Motor Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital fund investing in tech sectors
|
Locked | Locked | Locked | |
|
Investment solutions are provided by Catapult Ventures for growth.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Strella Biotech
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Strella Biotech
Investment portfolio details for Strella Biotech
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Strella Biotech
Detailed financials for Strella Biotech
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Strella Biotech Comparisons
Peer comparison for Strella Biotech
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Strella Biotech
Strella Biotech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Allergy Amulet, ClariFruit, SensoGenic, Crystal Diagnostics and Dots, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Portable food allergen sensors are offered via an online platform.
|
|
| Locked | Locked | Locked |
Developer of app-based quality control software for fruits and vegetables
|
|
| Locked | Locked | Locked |
Diagnostics biosensors for food allergens are provided by SensoGenic.
|
|
| Locked | Locked | Locked |
Patented biosensors for detecting pathogens in food produce are developed.
|
|
| Locked | Locked | Locked |
Mobile casual and puzzle games are developed by Dots.
|
Detailed competitors of Strella Biotech
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Strella Biotech
Complete news archive for Strella Biotech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Strella Biotech
Strella Biotech was founded in 2018 and raised its 1st funding round 2 years after it was founded.
Strella Biotech is headquartered in Philadelphia, United States. It is registered at Philadelphia, Pennsylvania, United States.
Strella Biotech is a funded company, having raised a total of $11.32M across 4 funding rounds to date.
As of Dec 31, 2021, the latest employee count at Strella Biotech is 12.
Strella Biotech is a manufacturer of gas chromatography biosensors for sensing the ripeness of fruits. It can be installed in controlled atmosphere storage rooms to monitor fruits as they ripen, supporting packers and distributors in identifying the location of their ripest and readiest fruits. It claims to minimize the spoilage and quality downgrade cost and helps to reduce food waste. It has won multiple awards and competitions including awards at the third annual Innovation Open competition.
Strella Biotech's top competitors include Dots, Allergy Amulet and ClariFruit.
Strella Biotech offers Store, Ripen, Sequence, and Monitor.
Strella Biotech has 12 investors. Key investors include Union Labs, Catapult Ventures, Yamaha Motor Ventures, Rich Products Ventures, and Google Ventures.